The first OncoConnect CAR-T Therapy Regional Summit: CAR-T in the Community happened in Fort Worth, TX mid April. At the invite of one of our practice partners (CCBD), CEO Brian Decker participated in the Best Practices in Community CAR-T: Start-Up Journeys and Lessons Learned panel. The panelists, including Michael Byrne, DO Medical Director of Cellular Therapy, One Oncology; Stephen Wrzesinski, MD, PhD, New York Oncology Hematology, led by moderator Carlton Sedberry, CEO, Immunobridge discussed real-world case-studies from their CAR-T start-up journeys. These unique perspectives from community oncology practices, support centers, and their data partners covered early planning, program growth, infrastructure, training, and data-driven methodology and outcomes.
Pictured from left to right: Michael Byrne, DO Medical Director of Cellular Therapy, One Oncology; Stephen Wrzesinski, MD, PhD, New York Oncology Hematology, Brian Decker, MBA, EMOL Health, led by moderator Carlton Sedberry, CEO, Immunobridge